Menu Menu

ELTP    Elite Pharmaceuticals Inc nv    1053369    
Income Statement
Revenue 14,364,248
Net Income -10,891,940
Profit Margin -75.83%

Balance Sheet
Current Assets 48,049,677
Assets 90,756,464
Current Liabilities 14,688,832
Liabilities 54,310,806
Equity 36,445,658
Shares Out 1,068,273,000

Cash Flow Statement
Operating Cash Flow 3,537,608
Investing Cash Flow -1,645,722

Market Analysis
Market Cap 411,185,722
Price 0.47
BVPS 0.03
PB 13.78
EPS 0.02
PE 20.12
PS 7.16
FCF 1,891,886
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/13 -0.01
Apr May Jun
Jul Aug Sep
7/01 0.02 8/14
Oct Nov Dec
11/14

Find a discrepancy? The most accurate way to find company fundamental data is to view ELTP documents filed with the SEC.


ELTP Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: